Cardiovascular Drugs Practice Questions

Q: Which of the following drugs is used in severe hypertensive emergencies, is very short acting, and must be given by i.v. infusion?

Nitroprusside. **Explanation:** **Sodium Nitroprusside** is the drug of choice for hypertensive emergencies because it is a potent, balanced vasodilator (acting on both arterioles and venules). Its mechanism involves the release of nitric oxide (NO), which increases cGMP levels, leading to smooth muscle relaxation. The key features that make it the correct answer are: 1. **Rapid Onset:** It acts within seconds. 2. **Ultra-short Duration:** Its effect lasts only 1–5 minutes after stopping the infusion, allowing for precise "minute-to-minute" titration of blood pressure. 3. **Administration:** It is unstable in light and must be administered via continuous intravenous infusion using an infusion pump. **Analysis of Incorrect Options:** * **Diazoxide (A):** An arteriolar vasodilator formerly used for emergencies. However, it has a long half-life (24 hours) and can cause reflex tachycardia and hyperglycemia, making it less ideal than Nitroprusside. * **Hydralazine (B):** Primarily an arteriolar vasodilator. It is used in pregnancy-induced hypertension (Eclampsia) but has a slower onset and less predictable offset compared to Nitroprusside. * **Labetalol (C):** A combined alpha and beta-blocker. While used in hypertensive emergencies (especially aortic dissection), it can be given as an IV bolus and has a much longer duration of action (3–6 hours). **High-Yield Clinical Pearls for NEET-PG:** * **Cyanide Toxicity:** Nitroprusside metabolism releases cyanide. Toxicity is managed with **Sodium Thiosulfate** (donates sulfur) or **Hydroxocobalamin** (binds cyanide to form Cyanocobalamin). * **Light Sensitivity:** Nitroprusside solutions must be wrapped in aluminum foil to prevent photodegradation. * **Thiocyanate Toxicity:** Prolonged infusion can lead to thiocyanate accumulation, especially in patients with renal failure, causing psychosis and seizures.

Q: Which of the following drugs acts as both a potassium channel opener and a nitric oxide donor?

Nicorandil. **Explanation:** **Nicorandil** is a unique anti-anginal agent characterized by a **dual mechanism of action**. It contains a nitrate moiety, allowing it to act as a **Nitric Oxide (NO) donor**, which increases cGMP levels leading to systemic venous dilation (preload reduction). Simultaneously, it acts as an **ATP-sensitive Potassium channel (K⁺$_{ATP}$) opener**, causing efflux of potassium, membrane hyperpolarization, and subsequent closure of voltage-gated calcium channels. This results in arterial dilation (afterload reduction). This balanced dilation of both epicardial coronary arteries and peripheral vessels makes it effective in stable angina. **Analysis of Incorrect Options:** * **B. Diazoxide:** This is a potent K⁺$_{ATP}$ channel opener used in hypertensive emergencies and insulinomas (as it inhibits insulin release). However, it lacks NO-donating properties. * **C. Sodium Nitroprusside:** A powerful vasodilator used in hypertensive crises. It acts solely as an NO donor (increasing cGMP) to dilate both arterioles and venules but does not affect potassium channels. * **D. Minoxidil:** A prodrug (converted to minoxidil sulfate) that acts strictly as a K⁺$_{ATP}$ channel opener. It is used for refractory hypertension and topically for alopecia. **High-Yield Clinical Pearls for NEET-PG:** * **Preconditioning:** Nicorandil mimics "ischemic preconditioning," protecting the myocardium during episodes of ischemia. * **Side Effects:** A highly specific and examiner-favorite side effect of Nicorandil is **perianal, oral, or mucosal ulceration**. * **Contraindication:** Like other nitrates, it should not be co-administered with PDE-5 inhibitors (e.g., Sildenafil) due to the risk of severe hypotension.

Q: Which of the following drugs can be used for the treatment of hypertension in a diabetic patient, EXCEPT?

Hydrochlorothiazide. **Explanation:** In diabetic patients with hypertension, the primary goal of therapy is not only blood pressure control but also **renoprotection** and **metabolic neutrality**. **Why Hydrochlorothiazide (HCTZ) is the correct answer:** Thiazide diuretics like Hydrochlorothiazide are generally avoided as first-line agents in diabetics because they can cause **hyperglycemia** and **dyslipidemia**. They inhibit insulin release from the pancreas and decrease peripheral glucose utilization, leading to worsened glycemic control. Additionally, they can cause hyperuricemia and hypokalemia. While they can be used in low doses as add-on therapy, they are the "least preferred" among the given options for a diabetic patient. **Analysis of other options:** * **Captopril (ACE Inhibitor) & Losartan (ARB):** These are the **drugs of choice** for hypertensive diabetics. They provide significant renoprotection by dilating the efferent arteriole, reducing intraglomerular pressure, and slowing the progression of diabetic nephropathy (reducing albuminuria). * **Amlodipine (Calcium Channel Blocker):** CCBs are metabolically neutral, meaning they do not affect blood glucose or lipid levels. They are excellent second-line agents or alternatives if ACE inhibitors are not tolerated. **NEET-PG High-Yield Pearls:** * **DOC for HTN with Diabetes:** ACE Inhibitors (e.g., Enalapril) or ARBs (e.g., Telmisartan). * **Metabolic effects of Thiazides:** Remember the mnemonic **"Hyper-GLUC"** (Hyper-Glycemia, Hyper-Lipidemia, Hyper-Uricemia, Hyper-Calcemia). * **Beta-blockers in Diabetes:** Use with caution as they can mask the tachycardia associated with hypoglycemia (except for non-selective ones like Propranolol, which can also delay recovery from hypoglycemia). Carvedilol/Nebivolol are preferred if a BB is necessary.

Q: All of the following are true about ACE inhibitors except?

Captopril & lisinopril are prodrugs. **Explanation:** The correct answer is **D** because it is a false statement. In pharmacology, most ACE inhibitors are **prodrugs** (e.g., Enalapril, Ramipril, Perindopril) that require hepatic conversion to their active "-at" forms (e.g., Enalaprilat). However, **Captopril and Lisinopril are the two major exceptions; they are active drugs** and do not require metabolism by the liver to exert their effect. **Analysis of other options:** * **Option A:** ACE inhibitors are the **drugs of choice** for HTN in patients with DM and CKD because they are **nephroprotective**. They dilate the efferent arteriole, reducing intraglomerular pressure and decreasing proteinuria. * **Option B:** They are **contraindicated in Bilateral Renal Artery Stenosis (RAS)**. In RAS, glomerular filtration rate (GFR) is maintained by Angiotensin II-mediated constriction of the efferent arteriole. ACE inhibitors block this mechanism, leading to a precipitous drop in GFR and acute renal failure. * **Option C:** Most ACE inhibitors are excreted renally. However, **Fosinopril** (and Spirapril) undergoes balanced hepatobiliary and renal excretion, making it safer in patients with renal impairment as the liver compensates for decreased renal clearance. **High-Yield Clinical Pearls for NEET-PG:** * **Teratogenicity:** ACE inhibitors are contraindicated in pregnancy (cause fetal renal dysgenesis and skull hypoplasia). * **Side Effects:** Remember the mnemonic **CAPTOPRIL**: **C**ough (due to Bradykinin), **A**ngioedema, **P**roteinuria, **T**aste changes, **O**rthostatic hypotension, **P**regnancy contraindication, **R**enal artery stenosis contraindication, **I**ncreased potassium (Hyperkalemia), **L**eukopenia. * **Lisinopril** is the only ACE inhibitor not bound to plasma proteins.

Q: Which of the following antihypertensives is NOT used in pregnancy?

Enalapril. **Explanation:** The correct answer is **Enalapril**. **1. Why Enalapril is contraindicated:** Enalapril belongs to the class of **ACE Inhibitors (ACEIs)**. These drugs are strictly contraindicated in pregnancy (Category D) because they interfere with the fetal renin-angiotensin system. Exposure, particularly in the second and third trimesters, leads to **fetal renal dysgenesis**, which causes oligohydramnios. This results in the **"ACEI Fetopathy"** triad: pulmonary hypoplasia, limb contractures, and calvarial (skull) bone hypoplasia. They may also cause neonatal anuria and hypotension. **2. Why the other options are incorrect:** * **Methyldopa:** A centrally acting alpha-2 agonist. It is traditionally the **drug of choice** for chronic hypertension in pregnancy due to its long-term safety profile and lack of adverse effects on fetal hemodynamics. * **Hydralazine:** A direct vasodilator. It is a preferred agent for the **acute management** of hypertensive emergencies (severe pre-eclampsia/eclampsia), usually administered intravenously. * **Nifedipine:** A Calcium Channel Blocker (CCB). The oral (long-acting) form is widely used for maintenance, while the immediate-release form is used for acute blood pressure reduction. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Antihypertensives (Mnemonic: "He Loves My Neonate"):** **H**ydralazine, **L**abetalol (often considered first-line now), **M**ethyldopa, **N**ifedipine. * **Labetalol** is currently the most commonly used first-line agent in clinical practice due to its rapid onset and fewer side effects compared to Methyldopa. * **Contraindicated drugs:** ACEIs, ARBs (e.g., Losartan), Nitroprusside (risk of fetal cyanide poisoning), and Spironolactone (anti-androgenic effects). * **Diuretics** are generally avoided unless there is pulmonary edema, as they can further decrease placental perfusion.

Q: Digoxin may be used in the treatment of which of the following conditions?

Atrial fibrillation. **Explanation:** **Digoxin** is a cardiac glycoside primarily used for its positive inotropic and negative chronotropic effects. **Why Atrial Fibrillation (AF) is correct:** In AF, the atria generate rapid, disorganized electrical impulses. Digoxin is effective because it **increases vagal tone**, which slows conduction through the **Atrioventricular (AV) node**. By increasing the refractory period of the AV node, it limits the number of impulses reaching the ventricles, thereby controlling the ventricular rate. It is particularly useful in AF patients who also have heart failure. **Why the other options are incorrect:** * **Constrictive Pericarditis & Cardiac Tamponade:** These are **mechanical/restrictive** conditions where the heart cannot fill properly due to external pressure. Digoxin (an inotrope) cannot overcome this physical restriction; the primary treatment is surgical (pericardiectomy or pericardiocentesis). * **Diastolic Failure (HFpEF):** In diastolic failure, the heart's pumping ability is preserved, but relaxation is impaired. Digoxin increases intracellular calcium, which can further impair relaxation and worsen diastolic dysfunction. It is indicated for **Systolic Failure (HFrEF)**, not diastolic. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Inhibits Na+/K+ ATPase pump $\rightarrow$ increased intracellular Na+ $\rightarrow$ decreased Na+/Ca2+ exchange $\rightarrow$ increased intracellular Ca2+ (Inotropy). * **ECG Changes:** Characterized by the "reverse tick" sign or **Sagging ST-segment depression**. * **Toxicity:** Hypokalemia predisposes to Digoxin toxicity. The most common arrhythmia in toxicity is **PVCs**, while the most characteristic is **Non-paroxysmal atrial tachycardia with AV block**. * **Antidote:** Digibind (Digoxin-specific Fab fragments).

Q: Which of the following statements is true about nitrates?

All of the above. **Explanation:** Nitrates are potent vasodilators that act as prodrugs, releasing **Nitric Oxide (NO)**. The correct answer is **D (All of the above)** because each statement accurately describes their pharmacology and clinical utility. 1. **Mechanism of Action (Option A):** Nitrates release NO, which stimulates the enzyme **Guanylyl Cyclase**. This increases intracellular **cGMP** levels. Elevated cGMP activates protein kinase G, leading to the **dephosphorylation of Myosin Light Chain (MLC)**. Since phosphorylated MLC is required for contraction, its dephosphorylation results in smooth muscle relaxation. 2. **Metabolism (Option B):** Organic nitrates (like Nitroglycerin) undergo denitration in the liver and smooth muscle cells. This process is mediated by the enzyme **Glutathione S-reductase** (also known as organic nitrate reductase), which utilizes reduced glutathione. 3. **Clinical Use (Option C):** Beyond angina, nitrates relax non-vascular smooth muscles. In **Achalasia Cardia**, they help lower the Lower Esophageal Sphincter (LES) pressure, providing symptomatic relief (though they are typically second-line to surgical or endoscopic interventions). **High-Yield Clinical Pearls for NEET-PG:** * **Venodilation > Arteriodilation:** At therapeutic doses, nitrates primarily cause venodilation, decreasing **preload** and myocardial oxygen demand. * **Nitrate Tolerance:** Continuous use leads to "tachyphylaxis" due to the depletion of free sulfhydryl (-SH) groups. A "nitrate-free interval" of 8–12 hours is essential to restore sensitivity. * **Monday Disease:** Workers in dynamite factories exposed to nitrates develop tolerance during the week but lose it over the weekend, leading to headaches and dizziness upon returning on Monday. * **Contraindication:** Never co-administer with **Sildenafil** (PDE-5 inhibitors) as it causes synergistic cGMP accumulation, leading to life-threatening hypotension.

Q: In essential hypertension, which drug class has the least cardiovascular effect?

ACE inhibitor. **Explanation:** The question focuses on the "least cardiovascular effect," which in this context refers to the impact on **cardiac output (CO), heart rate (HR), and sympathetic reflexes.** **Why ACE Inhibitors (ACEIs) are the correct answer:** ACE inhibitors (e.g., Enalapril, Lisinopril) lower blood pressure primarily by reducing total peripheral resistance (TPR) through the inhibition of Angiotensin II formation. Crucially, they **do not significantly alter heart rate, stroke volume, or cardiac output** in patients with essential hypertension. Unlike direct vasodilators, ACEIs do not typically trigger reflex tachycardia because they reset the baroreceptor reflex and inhibit the sympathetic nervous system. This makes them "hemodynamically neutral" regarding cardiac performance in uncomplicated hypertension. **Analysis of Incorrect Options:** * **Clonidine (Centrally acting alpha-2 agonist):** Significantly decreases sympathetic outflow, leading to a marked **decrease in heart rate and cardiac output.** * **Beta-blockers:** Their primary mechanism involves **decreasing heart rate and myocardial contractility**, directly reducing cardiac output. * **Alpha-blockers (e.g., Prazosin):** By causing potent peripheral vasodilation, they often trigger **reflex tachycardia** and can cause postural hypotension, representing a significant cardiovascular compensatory effect. **High-Yield NEET-PG Pearls:** * **Drug of Choice:** ACEIs are the first-line treatment for hypertensive patients with **Diabetes Mellitus** (due to nephroprotective effects) and **Left Ventricular Hypertrophy** (reverses remodeling). * **Side Effects:** Look for the triad of **Cough** (due to Bradykinin), **Angioedema**, and **Hyperkalemia**. * **Contraindications:** ACEIs are strictly contraindicated in **pregnancy** (teratogenic) and **Bilateral Renal Artery Stenosis** (can precipitate acute renal failure).

Q: Nitrates act by which of the following mechanisms?

Activating guanyl cyclase and increasing cGMP. **Mechanism of Action: Nitrates** Nitrates (e.g., Nitroglycerin, Isosorbide dinitrate) are prodrugs that undergo metabolic conversion to release **Nitric Oxide (NO)**. 1. **Why Option B is Correct:** Nitric Oxide enters the vascular smooth muscle cells and activates the enzyme **Soluble Guanyl Cyclase (sGC)**. This enzyme catalyzes the conversion of GTP to **cyclic GMP (cGMP)**. Increased levels of cGMP activate Protein Kinase G, which leads to: * Dephosphorylation of the myosin light chain. * Sequestration of intracellular calcium. The end result is **smooth muscle relaxation**, leading to potent venodilation (reducing preload) and modest arteriodilation (reducing afterload). 2. **Why Other Options are Incorrect:** * **Option A:** Nitrates *increase* cGMP, not decrease it. Decreased cGMP would lead to vasoconstriction. * **Options C & D:** These involve the **Adenyl Cyclase–cAMP** pathway. This pathway is utilized by drugs like **Beta-2 agonists** (e.g., Salbutamol) or **Prostacyclins**, but not by Nitrates. **High-Yield Clinical Pearls for NEET-PG:** * **Venodilation > Arteriodilation:** At therapeutic doses, nitrates primarily act on veins, reducing **Preload** (the primary mechanism for relieving angina). * **Tachyphylaxis (Tolerance):** Continuous exposure leads to "nitrate tolerance" due to the depletion of free sulfhydryl (-SH) groups. A "nitrate-free interval" of 8–12 hours is required daily. * **Drug Interaction:** Never co-administer Nitrates with **Sildenafil (PDE-5 inhibitors)**. PDE-5 inhibitors prevent the breakdown of cGMP, leading to synergistic accumulation of cGMP and life-threatening hypotension. * **Side Effects:** Throbbing headache (due to meningeal artery dilation), flushing, and reflex tachycardia.

Question 1

Which of the following drugs is used in severe hypertensive emergencies, is very short acting, and must be given by i.v. infusion?

Accepted Answer

Nitroprusside

Answer

Diazoxide

Answer

Hydralazine

Answer

Labetalol

Question 2

Which of the following drugs acts as both a potassium channel opener and a nitric oxide donor?

Accepted Answer

Nicorandil

Answer

Diazoxide

Answer

Sodium nitroprusside

Answer

Minoxidil

Question 3

Which of the following drugs can be used for the treatment of hypertension in a diabetic patient, EXCEPT?

Accepted Answer

Hydrochlorothiazide

Answer

Losartan

Answer

Captopril

Answer

Amlodipine

Question 4

All of the following are true about ACE inhibitors except?

Accepted Answer

Captopril & lisinopril are prodrugs

Answer

Drug of choice for hypertension in Diabetes Mellitus and chronic kidney disease

Answer

They are contraindicated in Bilateral Renal Artery stenosis

Answer

Fosinopril is safe in renal failure

Question 5

Which of the following antihypertensives is NOT used in pregnancy?

Accepted Answer

Enalapril

Answer

Methyldopa

Answer

Hydralazine

Answer

Nifedipine

Question 6

Digoxin may be used in the treatment of which of the following conditions?

Accepted Answer

Atrial fibrillation

Answer

Constrictive pericarditis

Answer

Cardiac tamponade

Answer

Diastolic failure

Question 7

A 60-year-old patient with chronic liver disease and rheumatoid arthritis is to be treated with procainamide. He is already taking digoxin, hydrochlorothiazide, and potassium supplementation. Which of the following statements is relevant to this patient's treatment?

Accepted Answer

Hyperkalemia should be avoided to reduce the likelihood of procainamide toxicity.

Answer

A possible drug interaction with digoxin suggests that digoxin blood levels should be obtained before and after starting procainamide.

Answer

Procainamide cannot be used if the patient has asthma because it has a beta-blocking effect.

Answer

Procainamide is not active by the oral route.

Question 8

Which of the following statements is true about nitrates?

Accepted Answer

All of the above

Answer

Acts by raising CGMP which causes dephosphorylation of MLCK

Answer

Metabolized by glutathione reductase

Answer

Used in achalasia cardia

Question 9

In essential hypertension, which drug class has the least cardiovascular effect?

Accepted Answer

ACE inhibitor

Answer

Clonidine

Answer

Alpha blocker

Answer

Beta blocker

Question 10

Nitrates act by which of the following mechanisms?

Accepted Answer

Activating guanyl cyclase and increasing cGMP

Answer

Activating guanyl cyclase and decreasing cGMP

Answer

Activating adenyl cyclase and decreasing cAMP

Answer

Activating adenyl cyclase and increasing cAMP

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?